RE:Time for some News Mr Laflamme !!!1hot-techwoman wrote: No news since Dec21/2021 !
If you cant run the company and expand it like you have stated in previous Q's then it time to put it up for sale to get someone who can !!!
In Q3 2021, VIVO began to focus on leveraging its assets to create value in the medical cannabis segment in Canada, Australia and Germany. VIVO believes that leveraging these assets will generate long-term shareholder value and accelerate its path to profitability.
Thanks ...this might be a good product for you Vetteran Trader... its good for an Azz...LOL
VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace
Friday, February 11, 2022, 7:00 AM ET
Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced a partnership with Cicatrix Labs Ltd. ("Cicatrix Labs") to offer Assuage(TM) vaginal and rectal suppositories on VIVO's Canna Farms e-commerce marketplace.
"In keeping with our laser focused medical strategy, we are extremely proud to be the first legal medical marketplace in Canada to launch the broadest range of suppositories available to all Canadian patients," commented Ray Laflamme, Canna Farms' Co-Founder and VIVO's Chief Executive Officer. "We've listened to our patients and advocacy groups, and we have recognized an unmet need for this specialized dosage format to support various women's health conditions gastrointestinal health conditions affecting both men and women."
Assuage(TM) suppositories for vaginal and rectal use are available in two formulations: 50 mg cannabidiol (CBD), and 1:3 formulation of 10 mg tetrahydrocannabinol (THC) and 30 mg CBD, with 8 suppositories per tin package.
"Assuage means to 'ease, or make an unpleasant feeling less intense', and these suppositories were designed keeping patient comfort and efficacy in mind for those unable to obtain relief with oral or inhaled cannabis," commented Sarah Roberts, RPh, President and Founder of Cicatrix Labs. "Patients no longer have to purchase suppositories from the illegal market or make their own. Partnering with Canna Farms ensures broad access of this unique dosage format for tens of thousands of patients."